meglumine has been researched along with Nervous System Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, P; Buecker, A; Colosimo, C; Martucci, M; Raczeck, P; Roditi, G; Schneider, GK; Stroeder, J | 1 |
| Boucher, M; Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J | 1 |
| Tien, RD | 1 |
1 review(s) available for meglumine and Nervous System Diseases
| Article | Year |
|---|---|
Fat-suppression MR imaging in neuroradiology: techniques and clinical application.
Topics: Adipose Tissue; Artifacts; Contrast Media; Cranial Nerve Diseases; Drug Combinations; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Nervous System Diseases; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Spinal Diseases | 1992 |
2 other study(ies) available for meglumine and Nervous System Diseases
| Article | Year |
|---|---|
T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease.
Topics: Brain; Child; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Nervous System Diseases; Organometallic Compounds | 2017 |
Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
Topics: Analgesia; Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Drug Synergism; Hormone Antagonists; Hyperalgesia; Indoles; Injections, Intravenous; Injections, Spinal; Male; Meglumine; Morphine; Nervous System Diseases; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Touch | 2000 |